Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

970 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells.
Baharom F, Ramirez-Valdez RA, Tobin KKS, Yamane H, Dutertre CA, Khalilnezhad A, Reynoso GV, Coble VL, Lynn GM, Mulè MP, Martins AJ, Finnigan JP, Zhang XM, Hamerman JA, Bhardwaj N, Tsang JS, Hickman HD, Ginhoux F, Ishizuka AS, Seder RA. Baharom F, et al. Among authors: bhardwaj n. Nat Immunol. 2021 Jan;22(1):41-52. doi: 10.1038/s41590-020-00810-3. Epub 2020 Nov 2. Nat Immunol. 2021. PMID: 33139915 Free PMC article.
Active immunization of humans with dendritic cells.
Dhodapkar MV, Bhardwaj N. Dhodapkar MV, et al. Among authors: bhardwaj n. J Clin Immunol. 2000 May;20(3):167-74. doi: 10.1023/a:1006681312249. J Clin Immunol. 2000. PMID: 10941824 Review.
CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases.
Yuan J, Ginsberg B, Page D, Li Y, Rasalan T, Gallardo HF, Xu Y, Adams S, Bhardwaj N, Busam K, Old LJ, Allison JP, Jungbluth A, Wolchok JD. Yuan J, et al. Among authors: bhardwaj n. Cancer Immunol Immunother. 2011 Aug;60(8):1137-46. doi: 10.1007/s00262-011-1011-9. Epub 2011 Apr 5. Cancer Immunol Immunother. 2011. PMID: 21465316 Free PMC article. Review.
Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma.
Sabado RL, Pavlick A, Gnjatic S, Cruz CM, Vengco I, Hasan F, Spadaccia M, Darvishian F, Chiriboga L, Holman RM, Escalon J, Muren C, Escano C, Yepes E, Sharpe D, Vasilakos JP, Rolnitzsky L, Goldberg J, Mandeli J, Adams S, Jungbluth A, Pan L, Venhaus R, Ott PA, Bhardwaj N. Sabado RL, et al. Among authors: bhardwaj n. Cancer Immunol Res. 2015 Mar;3(3):278-287. doi: 10.1158/2326-6066.CIR-14-0202. Epub 2015 Jan 29. Cancer Immunol Res. 2015. PMID: 25633712 Free PMC article. Clinical Trial.
Cancer immunotherapy: dendritic-cell vaccines on the move.
Sabado RL, Bhardwaj N. Sabado RL, et al. Among authors: bhardwaj n. Nature. 2015 Mar 19;519(7543):300-1. doi: 10.1038/nature14211. Epub 2015 Mar 11. Nature. 2015. PMID: 25762139 No abstract available.
Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.
Finnigan JP Jr, Rubinsteyn A, Hammerbacher J, Bhardwaj N. Finnigan JP Jr, et al. Among authors: bhardwaj n. Oncology (Williston Park). 2015 Dec;29(12):970-2, 974-5. Oncology (Williston Park). 2015. PMID: 26676902 Free article. Review. No abstract available.
In situ vaccination for the treatment of cancer.
Hammerich L, Bhardwaj N, Kohrt HE, Brody JD. Hammerich L, et al. Among authors: bhardwaj n. Immunotherapy. 2016;8(3):315-30. doi: 10.2217/imt.15.120. Epub 2016 Feb 9. Immunotherapy. 2016. PMID: 26860335 Review.
970 results